Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-search-preview-high-loc· OpenAIHugging Face LMArena Search Arena 24K

You are a theoretical biologist working on somatic evolution. Can you compare the…

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with Perplexitysonar-reasoning-pro-high’s answer.
  1. User

    You are a theoretical biologist working on somatic evolution. Can you compare the mathematical approaches taken to infer clonal evolution here: https://www.biorxiv.org/content/10.1101/569566v1.full-text and here: https://www.biorxiv.org/content/10.1101/2021.12.15.472780v2.full-text

  2. Assistant

    The two preprints you provided focus on inferring clonal evolution in cancer, each employing distinct mathematical approaches.

    1. "Inferring the paths of somatic evolution in cancer" (https://www.biorxiv.org/content/10.1101/569566v1.full-text):

    This study introduces the Bayesian Mutation Landscape (BML), a probabilistic method designed to reconstruct ancestral genotypes from tumor samples. BML operates by analyzing cross-sectional genomic data to infer the sequence of mutation accumulation in cancer cells. It utilizes a Bayesian framework to model the likelihood of various evolutionary paths, considering the presence of recurrently mutated genes across different tumor samples. By doing so, BML identifies diverse evolutionary scenarios involved in tumor initiation and progression, providing a detailed understanding of the mutational landscape in cancers such as colorectal, glioblastoma, lung, and ovarian cancers[1].

    2. "Combining mutation and recombination statistics to infer clonal families in antibody repertoires" (https://www.biorxiv.org/content/10.1101/2021.12.15.472780v2.full-text):

    This research presents HILARy (High-precision Inference of Lineages in Antibody Repertoires), a method aimed at identifying clonal families within B-cell receptor repertoires. HILARy integrates probabilistic models that capture both mutation and recombination statistics, employing clustering techniques to achieve high inference accuracy. It leverages the phylogenetic signal of shared mutations to discern evolutionary relationships among B-cell clones. By combining these statistical approaches, HILARy effectively reconstructs the lineage and evolutionary dynamics of antibody repertoires, providing insights into B-cell diversity and function[2].

    Comparison of Mathematical Approaches:

    • Bayesian Framework vs. Probabilistic Models with Clustering:

      • BML employs a Bayesian framework to model the likelihood of different evolutionary paths, focusing on the sequence of mutation accumulation in cancer cells.
      • HILARy utilizes probabilistic models that account for mutation and recombination statistics, combined with clustering methods to infer clonal families in B-cell repertoires.
    • Data Focus:

      • BML analyzes cross-sectional genomic data from tumor samples to reconstruct ancestral genotypes and infer mutation sequences.
      • HILARy focuses on B-cell receptor sequencing data, integrating mutation and recombination information to identify clonal families.
    • Application Domain:

      • BML is applied to various cancers, including colorectal, glioblastoma, lung, and ovarian cancers, to understand tumor evolution.
      • HILARy is tailored for studying the diversity and evolution of B-cell repertoires, which is crucial for understanding immune responses.

    In summary, while both methods aim to infer clonal evolution, BML focuses on reconstructing mutation sequences in cancer cells using a Bayesian approach, whereas HILARy combines probabilistic modeling and clustering to elucidate the evolutionary dynamics of B-cell receptor repertoires.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.